Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bridging study investigating bioequivalence of apomorphine sublingual thin film strip.

Trial Profile

Bridging study investigating bioequivalence of apomorphine sublingual thin film strip.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Dec 2015

At a glance

  • Drugs Apomorphine (Primary) ; Apomorphine (Primary)
  • Indications Parkinson's disease
  • Focus Pharmacokinetics; Registrational
  • Sponsors Cynapsus Therapeutics
  • Most Recent Events

    • 10 Dec 2015 According to a Cynapsus Therapeutics media release, results of this study are expected to be submitted to the U.S. FDA as part of a U.S. new drug application (NDA) submission, as well as to European regulatory authorities as part of a European submission.
    • 10 Dec 2015 Status changed from planning to completed, according to a Cynapsus Therapeutics media release.
    • 18 Mar 2015 Planned initiation date changed from 1 Oct 2014 to 1 Jun 2015, as reported in a Cynapsus Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top